News from welichem biotech inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 22, 2014, 17:19 ET

Welichem Announces Termination of Asset Purchase Agreement and Update on Compulsory Acquisition

BURNABY, BC, July 22, 2014 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI) announces that it has entered into a termination agreement...

Jun 30, 2014, 18:38 ET

Welichem Responds to completion of Take-over Bid

BURNABY, BC, June 30, 2014 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI) has become aware through the issuance of a news release by...

Jan 02, 2014, 17:59 ET

Welichem Announces Changes of Directors

BURNABY, BC, Jan. 2, 2014 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI), announced today that Ryan B. Zeng has been appointed as a...

Oct 10, 2013, 00:01 ET

Welichem announces substantial issuer bid

VANCOUVER, Oct. 10, 2013 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company", TSX.V: WBI) announces today the results of its substantial...

Aug 30, 2013, 03:01 ET

Welichem announces substantial issuer bid

VANCOUVER, Aug. 30, 2013 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company", TSX.V: WBI) announces that it is making a substantial issuer...

Mar 28, 2013, 18:57 ET

Welichem Biotech Inc. enters into agreement to acquire rights to WBI-1001 in China, Taiwan, Macao and Hong Kong

VANCOUVER, March 28, 2013 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company") (TSXV:WBI) announced today that it has entered into an asset...

Mar 01, 2013, 19:35 ET

Welichem announces the Resignation of Lijuan Pang as a Director

BURNABY, BC, March 1, 2013 /CNW/ - Welichem Biotech Inc. (the "Company") (TSX-V: WBI), announced today that Mrs. Lijuan Pang has resigned as a...

Jul 31, 2012, 15:56 ET

Welichem and Stiefel, a GSK company, complete the acquisition by Stiefel of the novel anti-inflammatory agent, WBI-1001

VANCOUVER, July 31, 2012 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company" TSX.V: WBI) announces that Welichem and Stiefel, a GSK...

Jul 05, 2012, 18:02 ET

Welichem shareholders approve asset purchase agreement with Stiefel, a GSK company

VANCOUVER, July 5, 2012 /CNW/ - Welichem Biotech Inc. ("Welichem" or the "Company" TSX.V: WBI) announces that Welichem shareholders at a special...

May 30, 2012, 15:04 ET

Stiefel, a GSK company, enters into an agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis

VANCOUVER, May 30, 2012 /CNW/ - Stiefel, a GSK company, and Welichem Biotech Inc., have entered into  an agreement for the acquisition by...